2,3-dinor-thromboxane b2 and Hyperlipoproteinemia Type II

2,3-dinor-thromboxane b2 has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bräutigam, C; Bräutigam, R; Engelmann, B; Lorenz, R; Richter, WO	1

Other Studies

1 other study(ies) available for 2,3-dinor-thromboxane b2 and Hyperlipoproteinemia Type II

Article	Year
Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. Atherosclerosis, 1997, Volume: 131, Issue:1 Topics: Adult; Arachidonic Acid; Blood Component Removal; Blood Platelets; Humans; Hyperlipoproteinemia Type II; Immunosorbent Techniques; Lipoproteins, LDL; Male; Middle Aged; Phospholipids; Thromboxane A2; Thromboxane B2	1997

Article

Year

Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.

Atherosclerosis, 1997, Volume: 131, Issue:1

Topics: Adult; Arachidonic Acid; Blood Component Removal; Blood Platelets; Humans; Hyperlipoproteinemia Type II; Immunosorbent Techniques; Lipoproteins, LDL; Male; Middle Aged; Phospholipids; Thromboxane A2; Thromboxane B2

1997